Sweden
· Delayed Price · Currency is SEK Ascelia Pharma AB Statistics
Total Valuation
STO:ACE has a market cap or net worth of SEK 345.98 million. The enterprise value is 296.12 million.
| Market Cap | 345.98M |
| Enterprise Value | 296.12M |
Important Dates
The next estimated earnings date is Friday, May 16, 2025.
| Earnings Date | May 16, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:ACE has 96.11 million shares outstanding. The number of shares has increased by 60.15% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 96.11M |
| Shares Change (YoY) | +60.15% |
| Shares Change (QoQ) | +87.06% |
| Owned by Insiders (%) | 1.98% |
| Owned by Institutions (%) | 26.38% |
| Float | 92.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 23.48 |
| PS Ratio | n/a |
| PB Ratio | 4.38 |
| P/TBV Ratio | 15.82 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.70 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.32.
| Current Ratio | 1.35 |
| Quick Ratio | 1.31 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -18.39 |
Financial Efficiency
Return on equity (ROE) is -104.43% and return on invested capital (ROIC) is -47.38%.
| Return on Equity (ROE) | -104.43% |
| Return on Assets (ROA) | -37.35% |
| Return on Invested Capital (ROIC) | -47.38% |
| Return on Capital Employed (ROCE) | -86.29% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -7.28M |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -67.69% in the last 52 weeks. The beta is 1.00, so STO:ACE's price volatility has been similar to the market average.
| Beta (5Y) | 1.00 |
| 52-Week Price Change | -67.69% |
| 50-Day Moving Average | 3.05 |
| 200-Day Moving Average | 2.91 |
| Relative Strength Index (RSI) | 72.83 |
| Average Volume (20 Days) | 947,454 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -68.12M |
| Pretax Income | -80.12M |
| Net Income | -80.03M |
| EBITDA | -68.05M |
| EBIT | -68.12M |
| Earnings Per Share (EPS) | -1.48 |
Balance Sheet
The company has 75.26 million in cash and 25.40 million in debt, giving a net cash position of 49.86 million or 0.52 per share.
| Cash & Cash Equivalents | 75.26M |
| Total Debt | 25.40M |
| Net Cash | 49.86M |
| Net Cash Per Share | 0.52 |
| Equity (Book Value) | 78.94M |
| Book Value Per Share | 0.82 |
| Working Capital | 21.74M |
Cash Flow
| Operating Cash Flow | -62.84M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
STO:ACE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -60.15% |
| Shareholder Yield | -60.15% |
| Earnings Yield | -23.13% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |